Suppr超能文献

肺活量与慢性阻塞性肺疾病:瑞典心肺生物影像研究(SCAPIS)

Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).

作者信息

Torén Kjell, Olin Anna-Carin, Lindberg Anne, Vikgren Jenny, Schiöler Linus, Brandberg John, Johnsson Åse, Engström Gunnar, Persson H Lennart, Sköld Magnus, Hedner Jan, Lindberg Eva, Malinovschi Andrei, Piitulainen Eeva, Wollmer Per, Rosengren Annika, Janson Christer, Blomberg Anders, Bergström Göran

机构信息

Section of Occupational and Environmental Medicine, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Department of Public Health and Clinical Medicine, Division of Medicine/Respiratory Medicine, Umeå University, Umeå, Sweden.

出版信息

Int J Chron Obstruct Pulmon Dis. 2016 May 2;11:927-33. doi: 10.2147/COPD.S104644. eCollection 2016.

Abstract

BACKGROUND

Spirometric diagnosis of chronic obstructive pulmonary disease (COPD) is based on the ratio of forced expiratory volume in 1 second (FEV1)/vital capacity (VC), either as a fixed value <0.7 or below the lower limit of normal (LLN). Forced vital capacity (FVC) is a proxy for VC. The first aim was to compare the use of FVC and VC, assessed as the highest value of FVC or slow vital capacity (SVC), when assessing the FEV1/VC ratio in a general population setting. The second aim was to evaluate the characteristics of subjects with COPD who obtained a higher SVC than FVC.

METHODS

Subjects (n=1,050) aged 50-64 years were investigated with FEV1, FVC, and SVC after bronchodilation. Global Initiative for Chronic Obstructive Lung Disease (GOLD) COPDFVC was defined as FEV1/FVC <0.7, GOLDCOPDVC as FEV1/VC <0.7 using the maximum value of FVC or SVC, LLNCOPDFVC as FEV1/FVC below the LLN, and LLNCOPDVC as FEV1/VC below the LLN using the maximum value of FVC or SVC.

RESULTS

Prevalence of GOLDCOPDFVC was 10.0% (95% confidence interval [CI] 8.2-12.0) and the prevalence of LLNCOPDFVC was 9.5% (95% CI 7.8-11.4). When estimates were based on VC, the prevalence became higher; 16.4% (95% CI 14.3-18.9) and 15.6% (95% CI 13.5-17.9) for GOLDCOPDVC and LLNCOPDVC, respectively. The group of additional subjects classified as having COPD based on VC, had lower FEV1, more wheeze and higher residual volume compared to subjects without any COPD.

CONCLUSION

The prevalence of COPD was significantly higher when the ratio FEV1/VC was calculated using the highest value of SVC or FVC compared with using FVC only. Subjects classified as having COPD when using the VC concept were more obstructive and with indications of air trapping. Hence, the use of only FVC when assessing airflow limitation may result in a considerable under diagnosis of subjects with mild COPD.

摘要

背景

慢性阻塞性肺疾病(COPD)的肺量计诊断基于1秒用力呼气容积(FEV1)/肺活量(VC)的比值,该比值可以是固定值<0.7,或者低于正常下限(LLN)。用力肺活量(FVC)可作为VC的替代指标。第一个目的是比较在一般人群中评估FEV1/VC比值时,使用FVC和VC(以FVC或慢肺活量(SVC)的最高值来评估)的情况。第二个目的是评估COPD患者中SVC高于FVC的患者的特征。

方法

对年龄在50 - 64岁的1050名受试者进行支气管扩张后的FEV1、FVC和SVC检查。慢性阻塞性肺疾病全球倡议(GOLD)COPDFVC定义为FEV1/FVC <0.7,GOLDCOPDVC定义为使用FVC或SVC的最大值时FEV1/VC <0.7,LLNCOPDFVC定义为FEV1/FVC低于LLN,LLNCOPDVC定义为使用FVC或SVC的最大值时FEV1/VC低于LLN。

结果

GOLDCOPDFVC的患病率为10.0%(95%置信区间[CI] 8.2 - 12.0),LLNCOPDFVC的患病率为9.5%(95% CI 7.8 - 11.4)。当基于VC进行评估时,患病率更高;GOLDCOPDVC和LLNCOPDVC分别为16.4%(95% CI 14.3 - 18.9)和15.6%(95% CI 13.5 - 17.9)。与无任何COPD的受试者相比,基于VC被归类为患有COPD的额外受试者组的FEV1更低、喘息更多且残气量更高。

结论

与仅使用FVC相比,使用SVC或FVC的最高值计算FEV1/VC比值时,COPD的患病率显著更高。使用VC概念时被归类为患有COPD的受试者阻塞性更强且有气体潴留的迹象。因此,在评估气流受限情况时仅使用FVC可能会导致轻度COPD患者的诊断明显不足。

相似文献

1
Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
Int J Chron Obstruct Pulmon Dis. 2016 May 2;11:927-33. doi: 10.2147/COPD.S104644. eCollection 2016.
2
Measures of bronchodilator response of FEV, FVC and SVC in a Swedish general population sample aged 50-64 years, the SCAPIS Pilot Study.
Int J Chron Obstruct Pulmon Dis. 2017 Mar 22;12:973-980. doi: 10.2147/COPD.S127336. eCollection 2017.
4
Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV/FVC Ratio?
Chest. 2019 Sep;156(3):497-506. doi: 10.1016/j.chest.2019.02.001. Epub 2019 Feb 12.
5
Comparison of Forced and Slow Vital Capacity Maneuvers in Defining Airway Obstruction.
Respir Care. 2019 Jul;64(7):786-792. doi: 10.4187/respcare.06419. Epub 2019 Mar 19.
6
Fixed ratio or lower limit of normal for the FEV /VC ratio: relation to symptoms and extended lung function tests.
Clin Physiol Funct Imaging. 2017 May;37(3):263-269. doi: 10.1111/cpf.12294. Epub 2015 Oct 6.
9
Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
Int J Chron Obstruct Pulmon Dis. 2015 Mar 11;10:535-40. doi: 10.2147/COPD.S80765. eCollection 2015.

引用本文的文献

2
Lung nodule localization and size estimation on chest tomosynthesis.
J Med Imaging (Bellingham). 2025 Jan;12(Suppl 1):S13007. doi: 10.1117/1.JMI.12.S1.S13007. Epub 2024 Oct 28.
4
Pulmonary Function Tests: Easy Interpretation in Three Steps.
J Clin Med. 2024 Jun 22;13(13):3655. doi: 10.3390/jcm13133655.
5
Clinical relevance of lung function trajectory clusters in middle-aged and older adults.
ERJ Open Res. 2024 Feb 5;10(1). doi: 10.1183/23120541.00793-2023. eCollection 2024 Jan.
6
The Role of Pulmonary Function Testing in the Diagnosis and Management of COPD.
Respir Care. 2023 Jul;68(7):889-913. doi: 10.4187/respcare.10757.
7
Occupational risks for infection with influenza A and B: a national case-control study covering 1 July 2006-31 December 2019.
Occup Environ Med. 2023 Jul;80(7):377-383. doi: 10.1136/oemed-2022-108755. Epub 2023 May 16.
8
Ever Smoking is Not Associated with Performed Spirometry while Occupational Exposure and Respiratory Symptoms are.
Int J Chron Obstruct Pulmon Dis. 2023 Mar 17;18:341-348. doi: 10.2147/COPD.S394832. eCollection 2023.
10
The ratio FEV /FVC and its association to respiratory symptoms-A Swedish general population study.
Clin Physiol Funct Imaging. 2021 Mar;41(2):181-191. doi: 10.1111/cpf.12684. Epub 2020 Dec 22.

本文引用的文献

1
Spirometric reference equations for Swedish adults.
Clin Physiol Funct Imaging. 2017 Nov;37(6):640-645. doi: 10.1111/cpf.12349. Epub 2016 Feb 10.
2
COPD (confusion over proper diagnosis) in the zone of maximum uncertainty.
Eur Respir J. 2015 Nov;46(5):1525-6. doi: 10.1183/13993003.01368-2015.
3
The Swedish CArdioPulmonary BioImage Study: objectives and design.
J Intern Med. 2015 Dec;278(6):645-59. doi: 10.1111/joim.12384. Epub 2015 Jun 19.
4
5
Summarising published results from spirometric surveys of COPD: the problem of inconsistent definitions.
Int J Tuberc Lung Dis. 2014 Aug;18(8):998-1003. doi: 10.5588/ijtld.13.0910.
6
Official American Thoracic Society technical standards: spirometry in the occupational setting.
Am J Respir Crit Care Med. 2014 Apr 15;189(8):983-93. doi: 10.1164/rccm.201402-0337ST.
7
Importance of slow vital capacity in the detection of airway obstruction.
J Bras Pneumol. 2013 May-Jun;39(3):317-22. doi: 10.1590/S1806-37132013000300008.
8
Fixed ratio or lower limit of normal as cut-off value for FEV1/VC: an outcome study.
Respir Med. 2013 Sep;107(9):1460-2. doi: 10.1016/j.rmed.2013.06.016. Epub 2013 Jul 8.
9
COPD in Helsinki, Finland: socioeconomic status based on occupation has an important impact on prevalence.
Scand J Public Health. 2013 Aug;41(6):570-8. doi: 10.1177/1403494813484554. Epub 2013 Apr 18.
10
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验